tirzepatide and kidney issues Interplay of Chronic Disease the Effects of in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial tirzepatide and chronic kidney disease
Description
Semaglutide can affect the digestive system because it slows down the emptying of the stomach

Tirzepatide timing follows the same principle
Therefore, you may see no weight loss in weeks 1, 2, 3, or even 4

Clinical recommendations: Healthcare providers should exercise caution when considering compounded semaglutide for patients
In clinical studies in adults with type 2 diabetes, an average decrease in body weight was observed

doi: 10.1056/NEJMoa0807646 Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al